Le Lézard
Classified in: Health
Subjects: AWD, NPT

AlloSource Awards Dr. Kevin Shea The Annual Dr. Steven Gitelis Inspiration Award


CENTENNIAL, Colo., July 17, 2018 /PRNewswire-USNewswire/ -- AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that it will award Dr. Kevin Shea with its second annual Dr. Steven Gitelis Inspiration Award. The award honors a doctor or clinician that inspires AlloSource through his or her work in treating patients with allografts.

Dr. Shea recently joined the Stanford University School of Medicine as a professor of orthopedic surgery and also serves as director of the Stanford Children's Health Sports Medicine Program. He specializes in the treatment of knee ligament and cartilage injuries, osteochondritis dissecans (OCD), fractures, and pediatric trauma and is one of the founders of The ROCK Group, an organization dedicated to researching OCD and improving its treatment methods.

"I am honored to receive this award," said Dr. Shea.  "I look forward to continued advancements in the field of orthopedics."

Dr. Shea has been crucial in coordinating efforts between The ROCK Group and AlloSource in research on OCD and other pediatric orthopedic conditions.  Dr. Shea works tirelessly to find unique uses for donated allograft material for pediatric orthopedic applications. In 2018, Dr. Shea was a recipient of the American Academy of Orthopedic Surgeons (AAOS) Senior Achievement Award in recognition of his volunteer work for the AAOS and orthopedic community.

"Dr. Shea truly embodies the spirit of honoring the gift of tissue donation to help heal his patients," said Thomas Cycyota, AlloSource president and CEO. "His commitment to research and improving treatment methods using donated tissue is an inspiration to all of us at AlloSource. We admire his dedication to the profession of orthopedic surgery and to his patients."  

The award honors a physician who understands and embraces the use of donated human tissue in surgical applications. The award is named after Dr. Steven Gitelis, a highly regarded orthopedic surgeon and one of the founders of AlloSource.

About AlloSource
AlloSource is dedicated to advancing the science and use of transplantable allogeneic cells and tissue through pioneering research in regenerative therapies. The organization offers life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility. As a world leader in cell-based products, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource's products bridge the proven science of allografts with the advanced technology of cells. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org.  

Media Contact
Megan Duggan
AlloSource
720. 382. 2766
[email protected] 

                                                                                       

SOURCE AlloSource


These press releases may also interest you

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

at 17:49
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 17:33
The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the United States, announced the overwhelming success of its 2024 "Are You O-K+" campaign, which marked May 1 (5.1) as...

at 17:21
The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize cutting-edge tools to expedite antibody discovery and...

at 17:00
Zepp Health Corporation ("Zepp" or the "Company") , a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated April 30, 2024, notifying Zepp that it is...



News published on and distributed by: